Latest filing published 04 Nov 2025 for NovoCure Ltd, €1,860.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Mukund Paravasthu appears in our data through filings on Novocure Ltd shares, published by SEC (Form 4). In total, 21 filings cover trades dated from 1 November 2024 to 5 March 2026.
Every open-market trade on record is a sale: 15 sales worth €745k. Outside the open market, there are 6 share grants. So far in 2026, the count stands at no purchases and 4 sales.
On 5 March 2026 came the latest disclosure, an open-market sale for €62k in Novocure Ltd. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations